Akt1–/– and Akt1–/– Tregs display differential suppressive activity in vitro and in vivo. (A) CD4+CD25+ Tregs of WT, Akt1–/– and Akt1–/– mice were cultured with CFSE-labeled naïve CD4+CD25− Teffs in the presence of plate-bound anti-CD3 and anti-CD28 for 96 h. The proliferation of Teffs was determined by flow cytometry. (B) Naïve CD4+CD25− T cells from WT mice together with CD4+CD25+ T cells from WT, Akt1–/–, or Akt1–/– mice were adoptively transferred into Tcrb–/– mice (n = 5 per group) which were then immunized with MOG35–55 in CFA. The development of EAE was monitored. * p < 0.05; Mann-Whitney U test. (C) The CD4+IFN-γ+, CD4+IL-17+ T cells, and CD4+CD25+Foxp3+ T cells within the draining lymph node cells of the recipients were determined. * p< 0.05; Student t test. The data shown are one representative of three independent experiments.